Tag: Husseini K. Manji

Janssen depression medication esketamine nasal spray yields mixed results in phase 3 trial

pharmanewsdaily- September 23, 2018

Janssen Pharmaceutical Companies of Johnson & Johnson depression medication esketamine nasal spray did not meet expectations in a phase 3 trial in patients with treatment-resistant ... Read More